259 related articles for article (PubMed ID: 18425131)
1. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.
Bustamante JM; Bixby LM; Tarleton RL
Nat Med; 2008 May; 14(5):542-50. PubMed ID: 18425131
[TBL] [Abstract][Full Text] [Related]
2. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection.
Bixby LM; Tarleton RL
J Immunol; 2008 Aug; 181(4):2644-50. PubMed ID: 18684955
[TBL] [Abstract][Full Text] [Related]
3. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cells in Trypanosoma cruzi infection.
Padilla AM; Bustamante JM; Tarleton RL
Curr Opin Immunol; 2009 Aug; 21(4):385-90. PubMed ID: 19646853
[TBL] [Abstract][Full Text] [Related]
6. Differential phenotypic and functional profile of epitope-specific cytotoxic CD8
Egui A; López MC; Gómez I; Simón M; Segovia M; Thomas MC
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165629. PubMed ID: 31816438
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection.
Martin DL; Tarleton RL
J Immunol; 2005 Feb; 174(3):1594-601. PubMed ID: 15661921
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
[TBL] [Abstract][Full Text] [Related]
9. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients.
Albareda MC; Laucella SA; Alvarez MG; Armenti AH; Bertochi G; Tarleton RL; Postan M
Int Immunol; 2006 Mar; 18(3):465-71. PubMed ID: 16431876
[TBL] [Abstract][Full Text] [Related]
11. Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.
Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
Antimicrob Agents Chemother; 2009 Jan; 53(1):174-9. PubMed ID: 19001113
[TBL] [Abstract][Full Text] [Related]
12. Immunological exhaustion and functional profile of CD8
Pérez-Antón E; Egui A; Thomas MC; Simón M; Segovia M; López MC
Acta Trop; 2020 Feb; 202():105242. PubMed ID: 31669531
[TBL] [Abstract][Full Text] [Related]
13. Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection.
Pack AD; Collins MH; Rosenberg CS; Tarleton RL
PLoS Pathog; 2018 Nov; 14(11):e1007410. PubMed ID: 30419010
[TBL] [Abstract][Full Text] [Related]
14. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
15. Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During
Ambrosio LF; Insfran C; Volpini X; Acosta Rodriguez E; Serra HM; Quintana FJ; Cervi L; Motrán CC
Front Immunol; 2019; 10():631. PubMed ID: 30984194
[TBL] [Abstract][Full Text] [Related]
16. CD8
Lasso P; Mateus J; González JM; Cuéllar A; Puerta C
Methods Mol Biol; 2019; 1955():349-361. PubMed ID: 30868540
[TBL] [Abstract][Full Text] [Related]
17. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease.
Albareda MC; Laucella SA
Mem Inst Oswaldo Cruz; 2015 May; 110(3):414-21. PubMed ID: 25993507
[TBL] [Abstract][Full Text] [Related]
19. Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection.
Olivieri BP; Cotta-De-Almeida V; Araújo-Jorge T
Antimicrob Agents Chemother; 2002 Dec; 46(12):3790-6. PubMed ID: 12435678
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
